Seer, Inc. (SEER)
NASDAQ: SEER · Real-Time Price · USD
1.860
-0.050 (-2.62%)
At close: Oct 22, 2024, 4:00 PM
1.830
-0.030 (-1.61%)
After-hours: Oct 22, 2024, 6:41 PM EDT
Seer, Inc. Revenue
Seer, Inc. had revenue of $3.07M in the quarter ending June 30, 2024, a decrease of -23.35%. This brings the company's revenue in the last twelve months to $14.74M, down -11.32% year-over-year. In the year 2023, Seer, Inc. had annual revenue of $16.66M with 7.54% growth.
Revenue (ttm)
$14.74M
Revenue Growth
-11.32%
P/S Ratio
8.12
Revenue / Employee
$100,259
Employees
147
Market Cap
114.26M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Augmedix | 51.58M |
Assembly Biosciences | 21.48M |
Verastem | 10.00M |
CervoMed | 9.65M |
Quantum-Si incorporated | 1.70M |
Adagene | 815.75K |
Fractyl Health | 119.00K |
SEER News
- 2 days ago - Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer's, Population Health, and Xenotransplantation at HUPO 2024 - GlobeNewsWire
- 2 months ago - Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Seer Appoints Nicolas Roelofs to its Board of Directors - GlobeNewsWire
- 2 months ago - Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 3 months ago - Seer to Report Second Quarter 2024 Financial Results on August 8, 2024 - GlobeNewsWire
- 4 months ago - Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery - GlobeNewsWire
- 5 months ago - Seer Technology Access Center Provides Unprecedented Scale and Depth of Coverage for PrognomiQ's Early Cancer Detection Study - GlobeNewsWire
- 5 months ago - Lab Instrument Industry Update - New Commercial Entrants - Seeking Alpha